Clinical Trial Update: Clinical Study of LV009 Injection for the Treatment of Hematologic and Lymphoid Malignancies [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for LV009 injection in hematologic and lymphoid cancers, including Non-Hodgkin Lymphoma and Acute Lymphoblastic Leukemia, currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Non-hodgkin Lymphoma

Drugs mentioned

• LV009 injection

Snippet

Sponsor: PersonGen BioTherapeutics (Suzhou) Co., Ltd. | Conditions: Non-Hodgkin Lymphoma, Acute Lymphoblastic Leukemia | Phase 1 | Status: RECRUITING